| Income Statement |
| Total Revenue | 216.41K |
|
| Revenues (USD) | 216.41K |
| Cost of Revenue | 32.82K |
| Gross Profit | 183.60K |
| Operating Expenses | 7.46M |
| Research and Development Expense | 1.81M |
| Selling, General and Administrative Expense | 5.66M |
| Operating Income | -7.28M |
| Net Income | -7.33M |
| Net Income Common Stock | -7.33M |
| Net Income Common Stock (USD) | -7.33M |
| Consolidated Income | -7.33M |
| Earnings per Basic Share | -0.45 |
| Earnings per Basic Share (USD) | -0.45 |
| Earnings per Diluted Share | -0.45 |
| Earning Before Interest & Taxes (EBIT) | -7.33M |
| Earning Before Interest & Taxes (USD) | -7.33M |
| Weighted Average Shares | 16.33M |
| Weighted Average Shares Diluted | 16.33M |
| Balance Sheet |
| Cash and Equivalents | 25.29M |
| Cash and Equivalents (USD) | 25.29M |
| Trade and Non-Trade Receivables | 95.58K |
| Current Assets | 32.99M |
| Property, Plant & Equipment Net | 570.20K |
| Total Assets | 33.94M |
| Debt Current | 866.55K |
| Total Debt | 905.30K |
| Current Liabilities | 2.69M |
| Debt Non-Current | 38.76K |
| Total Liabilities | 2.73M |
| Accumulated Retained Earnings (Deficit) | -22.38M |
| Accumulated Other Comprehensive Income | 195.50K |
| Shareholders Equity | 31.21M |
| Shareholders Equity (USD) | 31.21M |
| Assets Non-Current | 943.20K |
| Total Debt (USD) | 905.30K |
| Deferred Revenue | 107.12K |
| Goodwill and Intangible Assets | 97.67K |
| Liabilities Non-Current | 38.76K |
| Trade and Non-Trade Payables | 204.80K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 73.99K |
| Net Cash Flow from Financing | 8.77M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.82M |
| Capital Expenditure | -223.67K |
| Issuance (Purchase) of Equity Shares | 8.83M |
| Issuance (Repayment) of Debt Securities | -55.47K |
| Net Cash Flow from Investing | -321.33K |
| Net Cash Flow from Operations | -6.86M |
| Effect of Exchange Rate Changes on Cash | 227.89K |
| Share Based Compensation | 1.18M |